Lefrancois L, Goodman T
Department of Cell Biology, Upjohn Company, Kalamazoo, MI 49001.
J Immunol. 1987 Dec 1;139(11):3718-24.
The T200 glycoproteins of T cells were analyzed at different stages of T cell development. Immunoprecipitation and analysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed that Lyt-2-L3T4-, and Lyt-2+L3T4+ thymocytes had similar T200 proteins, whereas Lyt-2+L3T4- and Lyt-2-L3T4+ thymocytes expressed a distinct set of T200 molecules. This result indicated a molecular switch in regulation of T200 protein expression upon differentiation of thymocytes to mature phenotype T cells. Further modifications were evident when the T200 proteins of peripheral T cell subsets were examined. In particular L3T4+ T cells expressed T200 proteins of m.w. 220,000, 200,000, and 175,000, whereas Lyt-2+ lymph node T cells expressed an additional T200 protein of m.w. 235,000. Antigenic differences in the T200 glyco-proteins of peripheral L3T4+ and Lyt-2+ T cells were also detected. The anti-B220 monoclonal antibody, 14.8, reacted with lymph node Lyt-2+ T cells but did not react with lymph node L3T4+T cells or with Lyt-2+L3T4- thymocytes. This finding demonstrated a lineage-specific modification of the T200 protein of Lyt-2+ T cells that occurred after exit of these cells from the thymus into peripheral lymphoid organs. This modification apparently occurred on the m.w. 235,000 and 220,000 proteins since these species were precipitated by 14.8, whereas the others were not. In vitro growth and activation also resulted in further T200 antigen alterations. The monoclonal antibody, RA3, which reacts with the B220 antigen of B cells but, unlike 14.8, does not react with any peripheral T cells, showed significant reactivity with Lyt-2+ cytotoxic T cell (CTL) clones but not with L3T4+ T helper cell clones. CTL clones were also 14.8+ but T helper cell clones were not. Immunoprecipitation by 14.8 and RA3 of T200 proteins from CTL clones yielded a single protein of m.w. 240,000 that co-migrated with the B cell form of T200. Overall, the results indicate the presence of developmentally regulated mechanisms that control T200 glycoprotein expression during T cell differentiation in the thymus and in peripheral lymphoid organs.
在T细胞发育的不同阶段对T细胞的T200糖蛋白进行了分析。通过免疫沉淀和十二烷基硫酸钠-聚丙烯酰胺凝胶电泳分析发现,Lyt-2-L3T4-和Lyt-2+L3T4+胸腺细胞具有相似的T200蛋白,而Lyt-2+L3T4-和Lyt-2-L3T4+胸腺细胞表达一组不同的T200分子。这一结果表明,在胸腺细胞分化为成熟表型T细胞时,T200蛋白表达的调节存在分子开关。当检查外周T细胞亚群的T200蛋白时,进一步的修饰很明显。特别是L3T4+T细胞表达分子量为220,000、200,000和175,000的T200蛋白,而Lyt-2+淋巴结T细胞表达另外一种分子量为235,000的T200蛋白。还检测到外周L3T4+和Lyt-2+T细胞的T200糖蛋白的抗原差异。抗B220单克隆抗体14.8与淋巴结Lyt-2+T细胞反应,但不与淋巴结L3T4+T细胞或Lyt-2+L3T4-胸腺细胞反应。这一发现证明了Lyt-2+T细胞的T200蛋白在这些细胞从胸腺进入外周淋巴器官后发生了谱系特异性修饰。这种修饰显然发生在分子量为235,000和220,000的蛋白上,因为这些蛋白可被14.8沉淀,而其他蛋白则不能。体外生长和激活也导致T200抗原进一步改变。与B细胞的B220抗原反应但与14.8不同、不与任何外周T细胞反应的单克隆抗体RA3,与Lyt-2+细胞毒性T细胞(CTL)克隆有显著反应,但与L3T4+辅助性T细胞克隆无反应。CTL克隆也是14.8+,但辅助性T细胞克隆不是。用14.8和RA3对CTL克隆的T200蛋白进行免疫沉淀,得到一种分子量为240,000的单一蛋白,它与T200的B细胞形式共迁移。总体而言,结果表明存在发育调控机制,在胸腺和外周淋巴器官的T细胞分化过程中控制T200糖蛋白的表达。